Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Class A common stock, par value $0.0001 per share
-
Shares outstanding
-
1,261,707
-
Total 13F shares
-
6,958,359
-
Share change
-
-98,730
-
Total reported value
-
$71,407,231
-
Price per share
-
$10.29
-
Number of holders
-
28
-
Value change
-
-$985,233
-
Number of buys
-
3
-
Number of sells
-
8
Institutional Holders of Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (DNQAF) as of Q4 2022
As of 31 Dec 2022,
Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (DNQAF) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,958,359 shares.
The largest 10 holders included
Shaolin Capital Management LLC, Polar Asset Management Partners Inc., Hudson Bay Capital Management LP, MIZUHO SECURITIES USA LLC, ATW SPAC MANAGEMENT LLC, BOOTHBAY FUND MANAGEMENT, LLC, Saba Capital Management, L.P., WOLVERINE ASSET MANAGEMENT LLC, Cubist Systematic Strategies, LLC, and Context Capital Management, LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.